Inagene Logo.jpg
Inagene Diagnostics Inc. and The Newly Institute partner to optimize treatment for Canadians living with pain and/or mental health conditions
November 16, 2021 06:00 ET | Inagene Diagnostics Inc.
TORONTO, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Canadian pharmacogenetic (PGx) testing provider, Inagene Diagnostics Inc., has partnered with The Newly Institute, an advanced network of medically...
Inagene Logo.jpg
Inagene Diagnostics Inc.’s CEO featured alongside global expert advocates highlighting pharmacogenomic (gene-drug compatibility) testing as a game-changing innovation to safeguard the health of Canadians
November 09, 2021 06:00 ET | Inagene Diagnostics Inc.
TORONTO, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Focused on The Future of Innovation, Personalized Medicine and Genomics, the 21st Annual Healthcare Summit brought together global healthcare experts,...
TIP_link_300x300.jpg
Intrathecal Pumps Market Size ($513.24Mn by 2028) Growth Forecast at 5.3% CAGR During 2021 to 2028 COVID Impact and Global Analysis by TheInsightPartners.com
October 07, 2021 07:08 ET | The Insight Partners
New York, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Intrathecal Pumps Market: Key InsightsAccording to our new research study on “Intrathecal Pumps Market to 2028 – Global Analysis and Forecast – by Type,...
trypf.png
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Leading Next Wave of Psychedelic Drug Development
September 30, 2021 08:30 ET | Tryp Therapeutics Inc.
NEW YORK, Sept. 30, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) announces the availability of a broadcast titled, “Investors Turning to Psychedelic...
trypf.png
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Redefining Standards, Refining Psychiatry
September 28, 2021 08:30 ET | Tryp Therapeutics Inc.
NEW YORK, Sept. 28, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"),...
TIP_link_300x300.jpg
Medical Photobiostimulation System Market to Outstrip $314.88 Million by 2028 Growing Sturdy at 6.3% CAGR - COVID-19 Impact and Global Analysis by TheInsightPartners.com
August 12, 2021 09:39 ET | The Insight Partners
Pune, INDIA., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Medical Photobiostimulation System Market: Key InsightsAccording to our new research study on “Medical Photobiostimulation System Market to 2028 –...
CCM Logo.jpg
Leaf411: Increase in Opioid-related Overdoses Creates Urgency to Educate on Cannabis Treatments for Chronic Pain
August 10, 2021 11:00 ET | The 9th Block
DENVER, Aug. 10, 2021 (GLOBE NEWSWIRE) -- According to the U.S. Department of Health and Human Services, two-thirds of all drug overdoses in the country involve an opioid, and overdose deaths...
Inagene Logo.jpg
Canada’s surgery backlog could lead to wave of new chronic pain and opioid dependencies
July 21, 2021 06:00 ET | Inagene Diagnostics Inc.
TORONTO, July 21, 2021 (GLOBE NEWSWIRE) -- As Canada’s vaccination rates climb and hospitals begin to tackle the mountain of postponed surgeries due to the pandemic, we are facing an echo epidemic...
SPR Therapeutics LOGO 361 TM.jpg
Multi-Center Study of SPRINT® PNS System for Chronic Low Back Pain Demonstrates Clinically Significant Improvements in Pain and Quality of Life
July 12, 2021 08:00 ET | SPR Therapeutics, Inc.
CLEVELAND, July 12, 2021 (GLOBE NEWSWIRE) -- In the largest, most rigorous study to date using the SPRINT® PNS System for chronic axial low back pain (LBP), patients that failed to find relief from...
ibn-iw-globe-2.png
InvestorBrandNetwork (IBN) Announces Latest Episode of Stock2Me Podcast featuring Tryp Therapeutics Inc. Chairman and CEO Greg McKee
June 17, 2021 08:17 ET | InvestorBrandNetwork (IBN)
LOS ANGELES, June 17, 2021 (GLOBE NEWSWIRE) -- (via InvestorWire) InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment...